Page last updated: 2024-12-05

4-bromotoluene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-bromotoluene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7805
CHEMBL ID1377077
SCHEMBL ID808
MeSH IDM0473465

Synonyms (63)

Synonym
1-bromo-4-methyl-benzene
4-bromotoluene
nsc6531
4-bromo-1-methylbenzene
p-bromotoluene
nsc-6531
106-38-7
1-methyl-4-bromobenzene
p-tolyl bromide
p-methylbromobenzene
toluene, p-bromo-
4-methylbromobenzene
4-methyl-1-bromobenzene
benzene, 1-bromo-4-methyl-
1-bromo-4-methylbenzene
p-methylphenyl bromide
inchi=1/c7h7br/c1-6-2-4-7(8)5-3-6/h2-5h,1h
NCGC00090876-01
4-tolyl bromide
ai3-28596
4-methylphenyl bromide
nsc 6531
parabromotoluene
einecs 203-391-8
hsdb 6015
ccris 5983
toluene, 4-bromo-
4-bromotoluene, 98%
B0661
AKOS000118945
NCGC00090876-02
cas-106-38-7
NCGC00258522-01
dtxcid804661
tox21_200969
dtxsid7024661 ,
9e349gq7eu ,
unii-9e349gq7eu
FT-0617928
4-bromotoluene [hsdb]
SCHEMBL808
bromo-4-methyl-benzene
4-bromo-toluene
4-bromo toluene
p-tolylbromide
4- bromotoluene
STR01413
CHEMBL1377077
mfcd00000109
STL483071
J-001583
J-514846
F1908-0065
4-bromotoluene, puriss., >=99.0% (gc)
para bromotoluene
p-bromo toluene
Q27272425
para-methylphenyl bromide
p-methylphenylbromide
4-methyl-bromobenzene
1-bromanyl-4-methyl-benzene
C5O ,
EN300-19369
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency2.65860.000221.22318,912.5098AID743042
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.00070.000214.376460.0339AID588532
estrogen nuclear receptor alphaHomo sapiens (human)Potency60.06440.000229.305416,493.5996AID743069
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1555240Octanol/water partition co-efficient, log P of compound by UV-spectrophotometry-based shake-flask method
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.20 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index72.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]